Computerized pharmacy surveillance and alert system for drug‐related problems. (12th January 2017)

• Record Type: Journal Article
• Authors: Ferrández, O.; Urbina, O.; Grau, S.; Mateu‐de‐Antonio, J.; Marin‐Casino, M.; Portabella, J.; Mojal, S.; Riu, M.; Salas, E.
• Is Part Of: Journal of clinical pharmacy and therapeutics. Volume 42:Number 2(2017)
• Page Start: 201
• Page End: 208
• Publication Date: 2017-01-12
• Subjects: alerts -- computerized prescriber order entry -- drug‐related problem -- pharmacy warning system -- prescription review; Clinical pharmacology -- Periodicals; Chemotherapy -- Periodicals; 615
• DOI: 10.1111/jcpt.12495
• Languages: English
• ISSNs: 0269-4727

Abstract

Summary: What is known and objective: Because of the impact of drug‐related problems (DRPs) on morbidity and mortality, there is a need for computerized strategies to increase drug safety. The detection and identification of the causes of potential DRPs can be facilitated by the incorporation of a pharmacy warning system (PWS) in the computerized prescriber order entry (CPOE) and its application in the routine validation of inpatient drug therapy. A limited number of studies have evaluated a clinical decision support system to monitor drug treatment. Most of these applications have utilized a small range of drugs with alerts and/or types of alert. The objective of this study was to describe the implementation of a PWS integrated in the electronic medical record (EMR). Methods: The PWS was developed in 2003–2004. Pharmacological information to generate drug alerts was entered on demographic data, drug dosage, laboratory tests related to the prescribed drug and drug combinations (interactions, duplications and necessary combinations). The PWS was applied in the prescription reviews conducted in patients admitted to the hospital in 2012. Results and discussion: Information on 83% of the drugs included in the pharmacopeia was introduced into the PWS, allowing detection of 2808 potential DRPs, representing 79·1% of all potential DRPs detected during the study period. Twenty per cent of PWS DRPs were clinically relevant, requiring pharmacist intervention. What is new and conclusion: The PWS detected most potential DRPs, thus increasing inpatient safety. The detection ability of the PWS was higher than that reported for other tools described in the literature.